tm logo
FARXIGA
Live/Registered
REGISTERED AND RENEWED

on 21 Nov 2024

Last Applicant/ Owned by

Astraallén

Södertälje

SE

SE-15185

Serial Number

86049285 filed on 27th Aug 2013

Registration Number

4638205 registered on 11th Nov 2014

in the Principal Register

Correspondent Address

Cara M. Kearney

Cara M. Kearney AstraZeneca Pharmaceuticals LP

Wilmington, DE 19850-5437

United States

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

FARXIGA

Pharmaceutical preparations for human use for the treatment and prevention of diabetes and metabolic disorders

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations for human use for the treatment and prevention of diabetes and metabolic disorders


First Use Date in General

21st Jan 2014

First Use Date in Commerce

21st Jan 2014

Mark Details


Serial Number

No 86049285

Mark Type

No Service/Collective Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
21st Nov 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
21st Nov 2024REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
21st Nov 2024REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
21st Nov 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
21st Aug 2024TEAS SECTION 8 & 9 RECEIVED
11th Nov 2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
22nd Jul 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
22nd Jul 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
22nd Jul 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
22nd Jul 2021TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS